Vortioxetine
Sold as Brintellix, Vorellix, Vortioxetine cipla, Vortioxetine unichem, Vortioxetine aspen, Brivor, Vortioxetine DYNA, Trintogen, Vortioxetine adco, Vortioxetine lundbeck, Netixev, Voxbrint, Elibrin, Vortioxetine zydus, Makollix, Brintomak
1-[2-(2,4-Dimethylphenyl)sulfanylphenyl]piperazine
Drag to rotate. Structure from PubChem CID 9966051.
Background
Registration
- Applicants
- 10
- Registrations
- 50
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Adcock ingram limited | Brintellix, Trintogen, Vortioxetine adco | 5 mg, 5 mg/ 10 mg/ 20 mg, 10 mg, 15 mg, 20 mg | 480429, 480430, 480431, 480432, 550129, 550130, 550131, 550132.129, 550133.13, 550134.131 | S5 | PIPIL |
| Cipla Medpro (Pty) Ltd | Vorellix, Vortioxetine cipla | 5, 10, 15, 20 | 530699, 530700, 530701, 530702, 530703.699, 530704.7, 530705.701, 530706.702 | S5 | PIPIL |
| Unichem SA (Pty) Ltd | Vortioxetine unichem | 5 mg, 10 mg, 20 mg | 540556, 540557, 540558 | S5 | None |
| Pharmacare limited û woodmeadCertificate held by Pharmacare limited | Vortioxetine aspen | 2,4 mg | 540702, 540703, 540704 | S5 | PIPIL |
| Pharma Dynamics (Pty) Ltd | Brivor, Vortioxetine DYNA | 5 mg, 10 mg, 20 mg | 550105, 550106, 550107, 550108.105, 550109.106, 550110.107 | S5 | None |
| H. Lundbeck (Pty) Ltd | Vortioxetine lundbeck | 5,10,15,20 mg | 550580, 550581, 550582, 550583 | S5 | PIPIL |
| Pps Pharmaceuticals (Pty) Ltd | Netixev | 5, 10, 20 | 550597, 550598, 550599 | S5 | None |
| Dr Reddyæs Laboratories (Pty) Ltd | Voxbrint | 5, 10, 20 | 550600.597, 550601.598, 550602.599 | S5 | None |
| Zydus Healthcare (Pty) Ltd | Elibrin, Vortioxetine zydus | 10, 20 | 550792, 550793, 550795.792, 550796.793 | S5 | None |
| Macleods Pharmaceuticals SA (Pty) Ltd | Makollix, Brintomak | 5, 10, 20 | 570578, 570579, 570580, 570581.578, 570582.579, 570583.580 | S5 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Brintellix 5 MG EACH TABLET CONTAINS :VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 5,0 mg | 5 mg | 48042948/1.2/0429 | Registered | S5 | None |
| Brintellix 10 MG EACH TABLET CONTAINS :VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 10,0 mg | 10 mg | 48043048/1.2/0430 | Registered | S5 | None |
| Brintellix 15 MG EACH TABLET CONTAINS :VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 15,0 mg | 15 mg | 48043148/1.2/0431 | Registered | S5 | None |
| Brintellix 20 MG EACH TABLET CONTAINS :VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 20,0 mg | 20 mg | 48043248/1.2/0432 | Registered | S5 | None |
| Vorellix 5 ECAH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 5,0 mg | 5Tablets | 53069953/1.2/0699Approved 27 July 2021 | Registered | S5 | PIPIL |
| Vorellix 10 ECAH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 10,0 mg | 10Tablets | 53070053/1.2/0700Approved 27 July 2021 | Registered | S5 | PIPIL |
| Vorellix 15 ECAH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 15,0 mg | 15Tablets | 53070153/1.2/0701Approved 27 July 2021 | Registered | S5 | PIPIL |
| Vorellix 20 ECAH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 20,0 mg | 20Tablets | 53070253/1.2/0702Approved 27 July 2021 | Registered | S5 | PIPIL |
| Vortioxetine cipla 5 ECAH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 5,0 mg | 5Tablets | 530703.69953/1.2/0703.699Approved 27 July 2021 | Registered | S5 | PIPIL |
| Vortioxetine cipla 10 ECAH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 10,0 mg | 10Tablets | 530704.753/1.2/0704.700Approved 27 July 2021 | Registered | S5 | PIPIL |
| Vortioxetine cipla 15 ECAH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 15,0 mg | 15Tablets | 530705.70153/1.2/0705.701Approved 27 July 2021 | Registered | S5 | PIPIL |
| Vortioxetine cipla 20 ECAH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 20,0 mg | 20Tablets | 530706.70253/1.2/0706.702Approved 27 July 2021 | Registered | S5 | PIPIL |
| Vortioxetine 5 MG unichem EACH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 5,0 mg | 5 mg | 54055654/1.2/0556 | Registered | S5 | None |
| Vortioxetine 10 MG unichem EACH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 10,0 mg | 10 mg | 54055754/1.2/0557 | Registered | S5 | None |
| Vortioxetine 20 MG unichem EACH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 20,0 mg | 20 mg | 54055854/1.2/0558 | Registered | S5 | None |
| Vortioxetine 5mg aspen VORTIOXETINE HYDROBROMIDE | 2,4 mgTablet | 54070254/1.2/0702Approved 22 November 2022 | Registered | S5 | PIPIL |
| Vortioxetine 10 MG aspen VORTIOXETINE HYDROBROMIDE | 2,4 mgTablet | 54070354/1.2/0703Approved 22 November 2022 | Registered | S5 | PIPIL |
| Vortioxetine 20 MG aspen VORTIOXETINE HYDROBROMIDE | 2,4 mgTablet | 54070454/1.2/0704Approved 22 November 2022 | Registered | S5 | PIPIL |
| Brivor 5 MG EACH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 5,0 mg | 5 mg | 55010555/1.2/0105 | Registered | S5 | None |
| Brivor 10 MG EACH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 10,0 mg | 10 mg | 55010655/1.2/0106 | Registered | S5 | None |
| Brivor 20 MG EACH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 20,0 mg | 20 mg | 55010755/1.2/0107 | Registered | S5 | None |
| Vortioxetine 5 MG DYNA EACH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 5,0 mg | 5 mg | 550108.10555/1.2/0108.105 | Registered | S5 | None |
| Vortioxetine 10 MG DYNA EACH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 10,0 mg | 10 mg | 550109.10655/1.2/0109.106 | Registered | S5 | None |
| Vortioxetine 20 MG DYNA EACH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 20,0 mg | 20 mg | 550110.10755/1.2/0110.107 | Registered | S5 | None |
| Trintogen 5 EACH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 5,0 mg | 5 mg/ 10 mg/ 20 mgTablet | 55012955/1.2/0129Approved 12 July 2022 | Registered | S5 | PIPIL |
| Trintogen 10 EACH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 10,0 mg | 5 mg/ 10 mg/ 20 mgTablet | 55013055/1.2/0130Approved 12 July 2022 | Registered | S5 | PIPIL |
| Trintogen 20 EACH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 20,0 mg | 5 mg/ 10 mg/ 20 mgTablet | 55013155/1.2/0131Approved 12 July 2022 | Registered | S5 | PIPIL |
| Vortioxetine 5 adco EACH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 5,0 mg | 5 mg/ 10 mg/ 20 mgTablet | 550132.12955/1.2/0132.129Approved 12 July 2022 | Registered | S5 | PIPIL |
| Vortioxetine 10 adco EACH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 10,0 mg | 5 mg/ 10 mg/ 20 mgTablet | 550133.1355/1.2/0133.130Approved 12 July 2022 | Registered | S5 | PIPIL |
| Vortioxetine 20 adco EACH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 20,0 mg | 5 mg/ 10 mg/ 20 mgTablet | 550134.13155/1.2/0134.131Approved 12 July 2022 | Registered | S5 | PIPIL |
| Vortioxetine 5 MG lundbeck EACH TABLET CONTAINS : VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 5,0 mg | 5,10,15,20 mgFilm-coated tablets | 55058055/1.2/0580Approved 30 January 2024 | Registered | S5 | PIPIL |
| Vortioxetine 10 MG lundbeck EACH TABLET CONTAINS : VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 10,0 mg | 5,10,15,20 mgFilm-coated tablets | 55058155/1.2/0581Approved 30 January 2024 | Registered | S5 | PIPIL |
| Vortioxetine 15 MG lundbeck EACH TABLET CONTAINS : VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 15,0 mg | 5,10,15,20 mgFilm-coated tablets | 55058255/1.2/0582Approved 30 January 2024 | Registered | S5 | PIPIL |
| Vortioxetine 20 MG lundbeck EACH TABLET CONTAINS : VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 20,0 mg | 5,10,15,20 mgFilm-coated tablets | 55058355/1.2/0583Approved 30 January 2024 | Registered | S5 | PIPIL |
| Netixev 5 EACH TABLET CONTAINS: VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 5,0 mg | 5 | 55059755/1.2/0597 | Registered | S5 | None |
| Netixev 10 EACH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 10,0 mg | 10 | 55059855/1.2/0598 | Registered | S5 | None |
| Netixev 20 EACH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 20,0 mg | 20 | 55059955/1.2/0599 | Registered | S5 | None |
| Voxbrint 5 EACH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 5,0 mg | 5 | 550600.59755/1.2/0600.597 | Registered | S5 | None |
| Voxbrint 10 EACH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 10,0 mg | 10 | 550601.59855/1.2/0601.598 | Registered | S5 | None |
| Voxbrint 20 EACH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 20,0 mg | 20 | 550602.59955/1.2/0602.599 | Registered | S5 | None |
| Elibrin 10 EACH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 10,0 mg | 10 | 55079255/1.2/0792 | Registered | S5 | None |
| Elibrin 20 EACH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 20,0 mg | 20 | 55079355/1.2/0793 | Registered | S5 | None |
| Vortioxetine 10 zydus EACH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE 10,0 mg | 10 | 550795.79255/1.2/0795.792 | Registered | S5 | None |
| Vortioxetine 20 zydus EACH TABLET CONTAINS VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 20,0 mg | 20 | 550796.79355/1.2/0796.793 | Registered | S5 | None |
| Makollix 5 EACH TABLET CONTAINS: VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 5,0 mg | 5 | 57057857/1.2/0578 | Registered | S5 | None |
| Makollix 10 EACH TABLET CONTAINS: VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 10,0 mg | 10 | 57057957/1.2/0579 | Registered | S5 | None |
| Makollix 20 EACH TABLET CONTAINS: VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 20,0 mg | 20 | 57058057/1.2/0580 | Registered | S5 | None |
| Brintomak 5 EACH TABLET CONTAINS: VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 5,0 mg | 5 | 570581.57857/1.2/0581.578 | Registered | S5 | None |
| Brintomak 10 EACH TABLET CONTAINS: VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 10,0 mg | 10 | 570582.57957/1.2/0582.579 | Registered | S5 | None |
| Brintomak 20 EACH TABLET CONTAINS: VORTIOXETINE HYDROBROMIDE EQUIVALENT TO VORTIOXETINE 20,0 mg | 20 | 570583.58057/1.2/0583.580 | Registered | S5 | None |
Regulatory status
Where S5 sits on the scale
Prescription-only, with tighter controls on repeats.
Schedule 5 medicines need a prescription, and repeat dispensing is capped at six months in total; the prescriber must state upfront how many times, and at what intervals, it may be repeated. Extra limits apply to some uses: if it is being used for its anxiolytic, antidepressant, tranquillising or analgesic properties, it cannot be prescribed for longer than six months without a further consultation. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S5, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it.
Consolidated Schedules listings for Vortioxetine hydrobromide equivalent to vortioxetine
S5: Vortioxetine
Consolidated Schedules 06 July 2026, line 9765
Pharmacological class: Psychoanaleptics (antidepressants). (class 1.2)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.